Drug Safety Symposium on February 14-15, 2024 in Dubai, United Arab Emirates

At the forefront of advancing drug safety, the maiden edition of Drug Safety Symposium is dedicated to upholding the highest standards through rigorous practices in pharmacovigilance, regulatory compliance, and quality assurance. Our esteemed Conference and Masterclass format serves as premier gathering, offering a dynamic platform for attendees to delve into the latest industry trends, stay abreast of regulatory changes, and unearth innovative solutions propelling the pharmaceutical industry into the future.

Committed to excellence, we foster an environment conducive to meaningful discussions, knowledge sharing, and collaboration. Our goal is to empower participants with insights that transcend traditional boundaries, ensuring a transformative and enriching experience. Join us as we navigate the evolving landscape of drug safety, shaping the future of pharmaceuticals through expertise, exploration, and collaboration.

Reasons to Attend

Critically appraise the founding principles of pharmacovigilance and landmark cases effecting change to recent drug safety issue

Explain key operational drug safety definitions

Demonstrate good pharmacovigilance practice and locate key sources of information and documentation

Critically discuss issues associated with global pharmacovigilance

Analyse the stages of drug development in terms of drug safety assessment and benefit risk

Critically explain the strengths and weakness of pharmacovigilance reporting systems

Identify and predict future challenges in drug safety and pharmacovigilance

WHO SHOULD ATTEND

Global QPPVs / Deputies

QPPV Office managers

Heads of Pharmacovigilance

Heads of Pharmacovigilance Technologies

Drug Safety Managers and Leaders

List of professionals who should consider attending a PV conference, along with their respective departments or designations:

Pharmacovigilance Professionals:

Pharmacovigilance Officers

Drug Safety Specialists

Pharmacovigilance Managers

Medical Safety Officers

Regulatory Affairs Specialists (with a focus on PV)

Regulatory Affairs Professionals:

Regulatory Affairs Managers

Regulatory Affairs Specialists

Regulatory Compliance Managers

Quality Assurance and Compliance Teams:

Quality Assurance Managers

Compliance Officers

Auditors

Clinical Research and Development Teams:

Clinical Research Managers

Clinical Project Managers

Clinical Research Associates

Pharmaceutical Executives:

CEOs, Managing Directors, General Managers

Patient Safety Officers

Representatives of Patient Advocacy Organizations

Regulatory Authorities Representatives: Officials from health regulatory agencies responsible for drug safety and surveillance

Clinical Trial Managers: Professionals overseeing clinical trials with a focus on safety monitoring

Independent consultants providing PV expertise

Drug Manufacturing and Quality Control Specialists: Professionals involved in ensuring drug quality and safety during manufacturing